HIV News and Research

RSS

Researchers discover promising approach to silence HIV infection

Researchers from The University of Texas Medical Branch at Galveston have discovered a new potential medication that works with an HIV-infected person's own body to further suppress the ever present but silent virus that available HIV treatments are unable to combat.

6 Aug 2019

Tuberculosis still looms large over a fourth of the world’s people

A new Danish study concludes that a quarter of the people on earth have the tuberculosis bacillus within their bodies. This disease preys on over 10 million people annually, and kills 2 million a year. It is Number 1 on the list of killer diseases, far above AIDS and other infections.

5 Aug 2019

HIV-infected elderly cancer patients have worse outcomes despite treatment

Elderly cancer patients who are HIV-positive, particularly those with prostate and breast cancers, have worse outcomes compared to cancer patients in the same age range who do not have HIV.

2 Aug 2019

Real burden of tuberculosis is probably higher than estimated, reports study

The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

2 Aug 2019

Novel palliative care approach for caregivers of children with rare diseases shows preliminary success

A novel palliative care intervention developed at Children's National Health System for caregivers of children and adolescents with rare diseases has shown preliminary success at helping families talk about potentially challenging medical decisions before a crisis occurs.

1 Aug 2019

Children born with HIV less likely to adhere to medications as they age, study finds

Children born with HIV in the U.S. were less likely to adhere to their medications as they aged from preadolescence to adolescence and into young adulthood, according to a new study led by researchers at Harvard T.H. Chan School of Public Health.

31 Jul 2019

Trump administration ‘open for business’ on drug imports from Canada

A year after calling proposals allowing Americans to import cheaper drugs from Canada a "gimmick," Health and Human Services Secretary Alex Azar said the federal government is "open for business" on such a strategy.

31 Jul 2019

UM researchers receive $14 million from NIH for cutting-edge HIV research

The National Institutes of Health has awarded University of Miami researchers $14 million for an ambitious seven-year project that will keep the Miller School of Medicine at the forefront of cutting-edge HIV research.

30 Jul 2019

Rutgers expert discusses how to stay safe as 'flesh-eating bacteria' move into new waters

Infections caused by the bacterium Vibrio vulnificus – known as "flesh eating" bacteria – are becoming more common in northern waters, whose surface temperatures are rising due to climate change.

30 Jul 2019

New protocol for HIV prevention drug reduces the number of pills required

Health officials and AIDS advocates in San Francisco hope to expand the use of an effective HIV prevention drug with a new approach that requires fewer pills than the standard once-a-day regimen.

29 Jul 2019

UChicago awarded $17 million grant to tackle opioid addiction in criminal justice settings

It's estimated that more than 130 people die every day from opioid-related drug overdoses. Particularly at risk are people transitioning through the criminal justice system, many of whom may already be struggling with complex issues spanning mental health, family instability and job and housing insecurity.

26 Jul 2019

Study reveals mechanism that may contribute to HIV-associated metabolic conditions

HIV-infected cells release vesicles that contain a viral protein called Nef, impairing cholesterol metabolism and triggering inflammation in uninfected bystander cells, according to a study published July 25 in the open-access journal PLOS Pathogens by Dmitri Sviridov of the Baker Heart and Diabetes Institute in Australia, and colleagues.

From PLOS ONE 26 Jul 2019

Researchers explore how HIV spreads in 3D tissue-like environments

The spread of pathogens like the human immunodeficiency virus (HIV) is often studied in a test tube, i.e. in two-dimensional cell cultures, even though it hardly reflects the much more complex conditions in the human body.

25 Jul 2019

Study identifies new mechanism that impacts HIV infection

A team of scientists led by Texas Biomed's Assistant Professor Smita Kulkarni, Ph.D. and Mary Carrington, Ph.D., at the Frederick National Laboratory for Cancer Research, published results of a study that pinpointed a long noncoding RNA molecule which influences a key receptor involved in HIV infection and progression of the disease.

25 Jul 2019

New vaccine shows promise against toughest HIV strains

A new study reports successful immunization against a so-far invincible “death star” strain of an HIV-related laboratory virus (SIVmac239) and another tough strain. The new approach also achieves long-term protection with a single dose, showing that gene therapy could allow broad and durable protection, based on a modified form of the CD4 protein that allows HIV entry into human cells.

24 Jul 2019

Vaginal ring used by most women for HIV prevention in open-label study

In an open-label study of women in southern and eastern Africa, a vaginal ring that is inserted once a month and slowly releases an antiviral drug was estimated to reduce the risk of HIV by 39%, according to statistical modeling.

24 Jul 2019

New vaccine containing DNA and recombinant proteins may protect from HIV

Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel vaccine consisting of DNA and recombinant proteins?proteins composed of a portion of an HIV protein and another unrelated protein.

24 Jul 2019

Tailored adherence strategies needed to engage young African women in consistent PrEP use

In a study of open-label Truvada as daily pre-exposure prophylaxis (PrEP) to prevent HIV among 427 young African women and adolescent girls, 95% initiated the HIV prevention strategy, and most used PrEP for the first three months.

24 Jul 2019

Folic acid supplementation mitigates risk of neural tube defects linked to HIV drug

Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early gestation.

24 Jul 2019

New analysis quantifies how stimulant treatment reduces serious outcomes of ADHD

An analysis of three previous studies of children and young adults with attention-deficit hyperactivity disorder quantifies for the first time the extent to which stimulant treatment reduces the development of mood disorders, school problems, conduct disorders, substance use disorders and other problems.

23 Jul 2019

HIV News and Research

Researchers discover promising approach to silence HIV infection

Tuberculosis still looms large over a fourth of the world’s people

HIV-infected elderly cancer patients have worse outcomes despite treatment

Real burden of tuberculosis is probably higher than estimated, reports study

Novel palliative care approach for caregivers of children with rare diseases shows preliminary success

Children born with HIV less likely to adhere to medications as they age, study finds

Trump administration ‘open for business’ on drug imports from Canada

UM researchers receive $14 million from NIH for cutting-edge HIV research

Rutgers expert discusses how to stay safe as 'flesh-eating bacteria' move into new waters

New protocol for HIV prevention drug reduces the number of pills required

UChicago awarded $17 million grant to tackle opioid addiction in criminal justice settings

Study reveals mechanism that may contribute to HIV-associated metabolic conditions

Researchers explore how HIV spreads in 3D tissue-like environments

Study identifies new mechanism that impacts HIV infection

New vaccine shows promise against toughest HIV strains

Vaginal ring used by most women for HIV prevention in open-label study

New vaccine containing DNA and recombinant proteins may protect from HIV

Tailored adherence strategies needed to engage young African women in consistent PrEP use

Folic acid supplementation mitigates risk of neural tube defects linked to HIV drug

New analysis quantifies how stimulant treatment reduces serious outcomes of ADHD

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News